Achieve Life Sciences (ACHV) Projected to Post Earnings on Tuesday

Achieve Life Sciences (NASDAQ:ACHV) is expected to issue its quarterly earnings data before the market opens on Tuesday, March 11th. Analysts expect Achieve Life Sciences to post earnings of ($0.30) per share for the quarter.

Achieve Life Sciences Price Performance

Shares of ACHV opened at $3.14 on Monday. Achieve Life Sciences has a fifty-two week low of $2.82 and a fifty-two week high of $5.59. The firm’s 50-day simple moving average is $3.25 and its two-hundred day simple moving average is $4.07. The stock has a market cap of $107.98 million, a PE ratio of -2.78 and a beta of 1.67. The company has a debt-to-equity ratio of 0.31, a quick ratio of 6.78 and a current ratio of 6.78.

Analyst Ratings Changes

Several analysts recently weighed in on ACHV shares. RODMAN&RENSHAW upgraded Achieve Life Sciences to a “strong-buy” rating in a research note on Thursday, November 14th. Rodman & Renshaw began coverage on Achieve Life Sciences in a report on Thursday, November 14th. They issued a “buy” rating and a $12.00 target price on the stock. Three investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Achieve Life Sciences has a consensus rating of “Buy” and a consensus target price of $15.75.

Achieve Life Sciences Company Profile

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.